Protagonist Therapeutics stock price target raised to $74 at Clear Street
PositiveFinancial Markets

Protagonist Therapeutics has received a boost as Clear Street has raised its stock price target to $74. This adjustment reflects growing confidence in the company's potential and could attract more investors. Such positive news is significant as it may lead to increased trading activity and a stronger market presence for Protagonist, highlighting its promising developments in the biotech sector.
— Curated by the World Pulse Now AI Editorial System